Literature DB >> 17320100

Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy.

Milton Hamblin1, David B Friedman, Salisha Hill, Richard M Caprioli, Holly M Smith, Michael F Hill.   

Abstract

Diabetic cardiomyopathy has been documented as an underlying etiology of heart failure (HF) among diabetics. Although oxidative stress has been proposed to contribute to diabetic cardiomyopathy, much of the evidence lacks specificity. Furthermore, whether alterations occur at the cardiac proteome level in diabetic cardiac complications with attendant oxidative stress remains unknown. Therefore, we sought to identify cardiac protein changes in relation to myocardial oxidative stress that are specific to diabetic cardiomyopathy. Diabetes was induced in rats by a single injection of streptozotocin (STZ). STZ-treated rats were examined for diabetic cardiomyopathy at 8 weeks post-STZ by left ventricular (LV) hemodynamic analysis. LV systolic pressure (LVSP), rate of pressure rise (+dP/dt), and rate of pressure decay (-dP/dt) were depressed while LV end-diastolic pressure (LVEDP) was increased. Myocardial oxidative stress was increased in STZ-diabetic rats, as indexed by significant increases in myocardial formation of 8-iso PGF(2alpha) and oxidized glutathione (GSSG). In-depth mining of the diabetic myocardial proteome by proteomic analysis utilizing two-dimensional difference gel electrophoresis and mass spectrometry (DIGE/MS) techniques revealed that a high proportion (12 of 24) of the altered proteins that could be identified by mass spectrometry were localized to the mitochondria. Down-regulation of antioxidant and anti-apoptotic proteins was also observed in STZ-diabetic hearts. These results characterize a specific 'type I diabetic' pattern of cardiac proteome changes indicative of diabetic cardiomyopathy presenting with higher oxidative stress, supporting the idea that analysis of isoprostane biosynthesis and protein expression profiles may be useful diagnostically to assess the efficacy of antioxidant therapies as prophylactic treatments against type I diabetes mellitus complications involving the heart.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320100      PMCID: PMC2677446          DOI: 10.1016/j.yjmcc.2006.12.018

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  53 in total

1.  Preliminary pharmacokinetics of streptozotocin, an antineoplastic antibiotic.

Authors:  A B Adolphe; E D Glasofer; W M Troetel; A J Weiss; R W Manthei
Journal:  J Clin Pharmacol       Date:  1977-07       Impact factor: 3.126

Review 2.  Diabetic cardiomyopathy.

Authors:  S W Zarich; R W Nesto
Journal:  Am Heart J       Date:  1989-11       Impact factor: 4.749

3.  A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids.

Authors:  D Wessel; U I Flügge
Journal:  Anal Biochem       Date:  1984-04       Impact factor: 3.365

4.  Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein.

Authors:  H L Yin; T P Stossel
Journal:  Nature       Date:  1979-10-18       Impact factor: 49.962

5.  Alterations in tissue antioxidant systems in the spontaneously diabetic (BB Wistar) rat.

Authors:  S A Wohaieb; D V Godin
Journal:  Can J Physiol Pharmacol       Date:  1987-11       Impact factor: 2.273

6.  Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes.

Authors:  Gang Ye; Naira S Metreveli; Rajakumar V Donthi; Shen Xia; Ming Xu; Edward C Carlson; Paul N Epstein
Journal:  Diabetes       Date:  2004-05       Impact factor: 9.461

7.  Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment.

Authors:  S A Wohaieb; D V Godin
Journal:  Diabetes       Date:  1987-09       Impact factor: 9.461

8.  Clinically unrecognized ventricular dysfunction in young diabetic patients.

Authors:  R R Mildenberger; B Bar-Shlomo; M N Druck; G Jablonsky; J E Morch; J D Hilton; A B Kenshole; N Forbath; P R McLaughlin
Journal:  J Am Coll Cardiol       Date:  1984-08       Impact factor: 24.094

9.  Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus.

Authors:  A S Jaffe; J J Spadaro; K Schechtman; R Roberts; E M Geltman; B E Sobel
Journal:  Am Heart J       Date:  1984-07       Impact factor: 4.749

Review 10.  Diabetic cardiomyopathy.

Authors:  F S Fein; E H Sonnenblick
Journal:  Prog Cardiovasc Dis       Date:  1985 Jan-Feb       Impact factor: 8.194

View more
  44 in total

Review 1.  Cardiovascular redox and ox stress proteomics.

Authors:  Vikas Kumar; Timothy Dean Calamaras; Dagmar Haeussler; Wilson Steven Colucci; Richard Alan Cohen; Mark Errol McComb; David Pimentel; Markus Michael Bachschmid
Journal:  Antioxid Redox Signal       Date:  2012-08-10       Impact factor: 8.401

2.  Right ventricular protein expression profile in end-stage heart failure.

Authors:  Yan Ru Su; Manuel Chiusa; Evan Brittain; Anna R Hemnes; Tarek S Absi; Chee Chew Lim; Thomas G Di Salvo
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

3.  Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin.

Authors:  Vishal R Mali; Ruizhuo Ning; Jieli Chen; Xiao-Ping Yang; Jiang Xu; Suresh S Palaniyandi
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-20

4.  Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction.

Authors:  Walter A Baseler; Erinne R Dabkowski; Courtney L Williamson; Tara L Croston; Dharendra Thapa; Matthew J Powell; Trust T Razunguzwa; John M Hollander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-03       Impact factor: 3.619

5.  Ginsenoside Rg1 ameliorates oxidative stress and myocardial apoptosis in streptozotocin-induced diabetic rats.

Authors:  Hai-tao Yu; Juan Zhen; Bo Pang; Jin-ning Gu; Sui-sheng Wu
Journal:  J Zhejiang Univ Sci B       Date:  2015-05       Impact factor: 3.066

6.  miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart.

Authors:  Walter A Baseler; Dharendra Thapa; Rajaganapathi Jagannathan; Erinne R Dabkowski; Tara L Croston; John M Hollander
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-03       Impact factor: 4.249

7.  Proteomics and mass spectrometry: what have we learned about the heart?

Authors:  Shaan Chugh; Colin Suen; Anthony Gramolini
Journal:  Curr Cardiol Rev       Date:  2010-05

8.  Cardioprotective effects of rutin via alteration in TNF-α, CRP, and BNP levels coupled with antioxidant effect in STZ-induced diabetic rats.

Authors:  Ravi Saklani; Suresh Kumar Gupta; Ipseeta Ray Mohanty; Binit Kumar; Sushma Srivastava; Rajani Mathur
Journal:  Mol Cell Biochem       Date:  2016-07-22       Impact factor: 3.396

Review 9.  Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart.

Authors:  Gregory Aubert; Rick B Vega; Daniel P Kelly
Journal:  Biochim Biophys Acta       Date:  2012-08-31

10.  Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants.

Authors:  Michael F Hill
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.